BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28139340)

  • 21. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy.
    Bogan RK; Roth T; Schwartz J; Miloslavsky M
    J Clin Sleep Med; 2015 Apr; 11(4):427-32. PubMed ID: 25580605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychosis in the context of sodium oxybate therapy.
    Langford J; Gross WL
    J Clin Sleep Med; 2011 Dec; 7(6):665-6. PubMed ID: 22171207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of γ-hydroxybutyrate (GHB) on driving as measured by a driving simulator.
    Liakoni E; Dempsey DA; Meyers M; Murphy NG; Fiorentino D; Havel C; Haller C; Benowitz NL
    Psychopharmacology (Berl); 2018 Nov; 235(11):3223-3232. PubMed ID: 30232528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
    Huang YS; Guilleminault C
    Pediatr Neurol; 2009 Jul; 41(1):9-16. PubMed ID: 19520267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms.
    J Toxicol Clin Toxicol; 2003; 41(2):131-5. PubMed ID: 12733850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.
    Liechti ME; Quednow BB; Liakoni E; Dornbierer D; von Rotz R; Gachet MS; Gertsch J; Seifritz E; Bosch OG
    Br J Clin Pharmacol; 2016 May; 81(5):980-8. PubMed ID: 26659543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gamma-hydroxybutyrate (GHB) for narcolepsy in adults: an updated systematic review and meta-analysis.
    Xu XM; Wei YD; Liu Y; Li ZX
    Sleep Med; 2019 Dec; 64():62-70. PubMed ID: 31671326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three deaths associated with use of Xyrem.
    Zvosec DL; Smith SW; Hall BJ
    Sleep Med; 2009 Apr; 10(4):490-3. PubMed ID: 19269893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of GHB in human hair by HPLC-MS/MS: Development and validation of a method and application to a study group and three possible single exposure cases.
    Bertol E; Mari F; Vaiano F; Romano G; Zaami S; Baglìo G; Busardò FP
    Drug Test Anal; 2015 May; 7(5):376-84. PubMed ID: 24947196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of sodium oxybate to treat narcolepsy.
    Mayer G
    Expert Rev Neurother; 2012 May; 12(5):519-29. PubMed ID: 22550980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefits and risk of sodium oxybate in idiopathic hypersomnia versus narcolepsy type 1: a chart review.
    Leu-Semenescu S; Louis P; Arnulf I
    Sleep Med; 2016 Jan; 17():38-44. PubMed ID: 26847972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increases in Serum Growth Hormone Concentrations Associated with GHB Administration.
    Brailsford AD; Bartlett C; Kicman AT; Cowan DA
    J Anal Toxicol; 2017 Jan; 41(1):54-59. PubMed ID: 27744373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy.
    Mamelak M; Black J; Montplaisir J; Ristanovic R
    Sleep; 2004 Nov; 27(7):1327-34. PubMed ID: 15586785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ
    Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a new metabolite of GHB: gamma-hydroxybutyric acid glucuronide.
    Petersen IN; Tortzen C; Kristensen JL; Pedersen DS; Breindahl T
    J Anal Toxicol; 2013 Jun; 37(5):291-7. PubMed ID: 23612681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb; 25(1):42-9. PubMed ID: 11833860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group
    J Clin Sleep Med; 2005 Oct; 1(4):391-7. PubMed ID: 17564408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium oxybate for narcolepsy.
    Scharf MB
    Expert Rev Neurother; 2006 Aug; 6(8):1139-46. PubMed ID: 16893342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of dispersive liquid-liquid microextraction and GC-MS/MS for the determination of GHB in beverages and hair.
    Meng L; Chen S; Zhu B; Zhang J; Mei Y; Cao J; Zheng K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1144():122058. PubMed ID: 32224437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
    Mansukhani MP; Kotagal S
    Sleep Med; 2012 Jun; 13(6):606-10. PubMed ID: 22445591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.